A convolutional neural network estimation of brain age is sensitive to cognitive impairment and decline
Yang, Y.; Sathe, A.; Schilling, K.; Shashikumar, N.; Moore, E.; Dumitrescu, L.; Pechman, K. R.; Landman, B. A.; Gifford, K. A.; Hohman, T. J.; Jefferson, A. L.; Archer, D. B.
Show abstract
The greatest known risk factor for Alzheimers disease (AD) is age. While both normal aging and AD pathology involve structural changes in the brain, their trajectories of atrophy are not the same. Recent developments in artificial intelligence have encouraged studies to leverage neuroimaging-derived measures and deep learning approaches to predict brain age, which has shown promise as a sensitive biomarker in diagnosing and monitoring AD. However, prior efforts primarily involved structural magnetic resonance imaging and conventional diffusion MRI (dMRI) metrics without accounting for partial volume effects. To address this issue, we post-processed our dMRI scans with an advanced free-water (FW) correction technique to compute distinct FW-corrected fractional anisotropy (FAFWcorr) and FW maps that allow for the separation of tissue from fluid in a scan. We built 3 densely connected neural networks from FW-corrected dMRI, T1-weighted MRI, and combined FW+T1 features, respectively, to predict brain age. We then investigated the relationship of actual age and predicted brain ages with cognition. We found that all models accurately predicted actual age in cognitively unimpaired (CU) controls (FW: r=0.66, p=1.62x10-32; T1: r=0.61, p=1.45x10-26, FW+T1: r=0.77, p=6.48x10-50) and distinguished between CU and mild cognitive impairment participants (FW: p=0.006; T1: p=0.048; FW+T1: p=0.003), with FW+T1-derived age showing best performance. Additionally, all predicted brain age models were significantly associated with cross-sectional cognition (memory, FW: {beta}=-1.094, p=6.32x10-7; T1: {beta}=-1.331, p=6.52x10-7; FW+T1: {beta}=-1.476, p=2.53x10-10; executive function, FW: {beta}=-1.276, p=1.46x10-9; T1: {beta}=-1.337, p=2.52x10-7; FW+T1: {beta}=-1.850, p=3.85x10-17) and longitudinal cognition (memory, FW: {beta}=-0.091, p=4.62x10-11; T1: {beta}=-0.097, p=1.40x10-8; FW+T1: {beta}=-0.101, p=1.35x10-11; executive function, FW: {beta}=-0.125, p=1.20x10-10; T1: {beta}=-0.163, p=4.25x10-12; FW+T1: {beta}=-0.158, p=1.65x10-14). Our findings provide evidence that both T1-weighted MRI and dMRI measures improve brain age prediction and support predicted brain age as a sensitive biomarker of cognition and cognitive decline.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Complementary value of molecular, phenotypic and functional aging biomarkers in dementia prediction 96%
- Beyond brain size: disentangling the effect of sex and brain size on brain morphometry and cognitive functioning 96%
- Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD 96%
Similar papers in this journal
- Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers 96%
- Integrating plasma, MRI, and cognitive biomarkers for personalized prediction of decline across cognitive domains 95%
- Myo-inositol and total NAA in the hippocampus are linked to CSF tau pathology in cognitively normal older adults 95%
Similar papers in this journal
- NeuropsychBrainAge: a biomarker for conversion from mild cognitive impairment to Alzheimer’s disease 96%
- The Temporal Relationships between White Matter Hyperintensities, Neurodegeneration, Amyloid β, and Cognition 95%
- Delayed primacy recall performance predicts post mortem Alzheimers disease pathology from unimpaired ante mortem cognitive baseline 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.